Phio Pharmaceuticals Corp(NASDAQ:PHIO) 
Phio Pharmaceuticals Corp., a biotechnology company, develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on silencing tumor-induced suppression of the immune system. The company develops PH-762, which targets the checkpoint protein PD-1 that pre...
Website: https://phiopharma.com/
Founded: 2011
Full Time Employees: 11
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.16
H 1.16
L 1.05
C 1.07
V 159,981
10EMA 1.07
20EMA 1.07
60EMA 1.07
120EMA 1.07
250EMA 1.07